Herantis Pharma Oyj announced that the following members have been appointed to its Shareholders' Nomination Committee: Marko Berg, Helsinki University Funds (HYR) (Chairman), Pia Gisgard, Swedbank Robur, Prihti, Inveni Life Sciences Fund I Ky, ja and Timo Veromaa, the Chairman of Herantis Pharma's Board of Directors. Herantis Pharma's Shareholders' Nomination Committee consists of four members, of which three represent the company's shareholders. The Chairman of Herantis Pharma's Board of Directors will serve as the fourth member of the Nomination Committee.